Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2881078 in COPD with Muscle Weakness
NCT03359473Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of GSK2881078 in muscle weakness, chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Feb 2018; status: completed.
02
Drugs
GSK2881078
03
Conditions
muscle weaknesschronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03359473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359473.